SoT
Showing 1 - 25 of 274
Pulmonary Vascular Disorder, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich
Active, not recruiting
- Pulmonary Vascular Disorder
- +2 more
- Supplemental oxygen therapy
- Sham Oxygen therapy
-
Zurich, SwitzerlandUniversity Hospital Zürich
Oct 9, 2023
Cytomegalovirus Infection Outcomes Among Solid Organ Transplant
Not yet recruiting
- Cytomegalovirus (CMV)
- (no location specified)
Oct 18, 2022
Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zürich
Recruiting
- Pulmonary Vascular Disease
- +2 more
- 6-minute walk distance (6MWD) test
- 6-minute walk distance (6MWD) test with supplemental oxygen (3 l/min, nasal)
-
Zürich, SwitzerlandUniversity Hospital Zürich
Aug 18, 2023
Breast Cancer, Breast Diseases Trial in Taipei (Define Standard of Truth (SOT) by Taihao Breast Cancer Diagnostic Software)
Active, not recruiting
- Breast Cancer
- Breast Diseases
- Define Standard of Truth (SOT) by Taihao Breast Cancer Diagnostic Software
-
Taipei, TaiwanTaiHao Medical Inc
Mar 28, 2023
Immunization; Infection, Transplantation Infection, Influenza Trial in Nashville (Standard Dose Quadrivalent Inactivated
Not yet recruiting
- Immunization; Infection
- +2 more
- Standard Dose Quadrivalent Inactivated Influenza Vaccine
- High Dose Quadrivalent Inactivated Influenza Vaccine
-
Nashville, TennesseeVanderbilt University Medical Center
Jul 11, 2023
Cutaneous Squamous Cell Carcinoma, Advanced Cancer Trial in Boston (Cemiplimab, Everolimus, Sirolimus)
Recruiting
- Cutaneous Squamous Cell Carcinoma
- Advanced Cancer
- Cemiplimab
- +3 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 19, 2023
Endobronchial Ultrasound Trial in Chandigarh (Standard oxygen therapy, HFNC)
Recruiting
- Endobronchial Ultrasound
- Standard oxygen therapy
- HFNC
-
Chandigarh, India
- +1 more
Jun 23, 2022
Pregnancy Related Trial (Sangobion and Thiamine Hydrochloride, Sangobion, Thiamine HCl and Vitamin B12)
Recruiting
- Pregnancy Related
- Sangobion and Thiamine Hydrochloride
- Sangobion, Thiamine hydrochloride and Vitamin B12
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit (SMRU)
Oct 21, 2022
Ganciclovir Resistant Cytomegalovirus Infection in SOT
Not yet recruiting
- Cytomegalovirus Infections
- (no location specified)
Feb 8, 2022
Immunization; Infection, Transplantation Infection, Influenza Trial in Nashville (High Dose Quadrivalent Inactivated Influenza
Recruiting
- Immunization; Infection
- +3 more
- High Dose Quadrivalent Inactivated Influenza Vaccine
- Standard Dose Quadrivalent Inactivated Influenza Vaccine
-
Nashville, TennesseeVanderbilt Univeristy Medical Center
May 27, 2022
Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
Not yet recruiting
- Covid-19 Pandemics
- Tuberculosis
- Pfizer-BioNTech COVID-19 vaccine
- +2 more
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit (SMRU)
Oct 21, 2022
COVID-19 Pandemic Trial in Mae Sot (STANDARD Q COVID-19 Ag Test)
Active, not recruiting
- COVID-19 Pandemic
- STANDARD Q COVID-19 Ag Test
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit
Dec 5, 2022
Healthy Lactating Women Trial in Mae Sot (Primaquine, Tafenoquine)
Not yet recruiting
- Healthy Lactating Women
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit (SMRU)
Jun 21, 2022
Malaria, Malaria, Vivax, Plasmodium Vivax Malaria Trial in Mae Sot (Dihydroartemisinin-piperaquine plus tafenoquine (450 mg
Not yet recruiting
- Malaria
- +2 more
- Dihydroartemisinin-piperaquine plus tafenoquine (450 mg adult dose)
- Chloroquine plus Tafenoquine (450 mg adult dose)
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit (SMRU)
Mar 15, 2023
Malaria Trial in Mae Sot (dihydroartemisinin-piperaquine, Artesunate-mefloquine, arthemeter-lumefantrin)
Completed
- Malaria
- dihydroartemisinin-piperaquine
- +2 more
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit
Mar 24, 2022
Plasmodium Falciparum Malaria Trial in Mae Sot (Ultrasensitive Rapid Diagnostic Test (URDT), Antimalarials)
Completed
- Plasmodium Falciparum Malaria
- Ultrasensitive Rapid Diagnostic Test (URDT)
- Antimalarials
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit
Feb 14, 2022
Scrub Typhus Trial in Mae Sot, Chiang Rai (Doxycycline 7 days, Doxycycline 3 days, Azithromycin 3 days)
Recruiting
- Scrub Typhus
- Doxycycline 7 days
- +2 more
-
Mae Sot, Tak, Thailand
- +1 more
Mar 22, 2022
Hepatitis B, Tenofovir, Pregnancy Trial in Mae sot (Tenofovir Disoproxil Fumarate)
Active, not recruiting
- Hepatitis B
- +2 more
- Tenofovir Disoproxil Fumarate
-
Mae sot, Tak, ThailandShoklo Malaria Research unit (SMRU) clinics
Mar 22, 2022
COVID19 Vaccine in SOT Adult Recipients
Recruiting
- COVID-19
- +6 more
- COVID19 mRNA vaccine
-
Milan, ItalyFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Mil
Nov 9, 2021
Febrile Illness in Health Facilities in Rural South and
Recruiting
- Acute Febrile Illness
-
Dhaka, Bangladesh
- +3 more
Dec 13, 2022
Malaria, Vivax, G6PD Deficiency Trial in Mae Sot (primaquine, chloroquine + primaquine)
Terminated
- Malaria, Vivax
- G6PD Deficiency
- primaquine
- chloroquine + primaquine
-
Mae Sot, ThailandShoklo Malaria Research Unit (SMRU)
Oct 15, 2021
Infection in Solid Organ Transplant Recipients Trial in Los Angeles (Pneumococcal Conjugate Vaccine 13 (PCV13))
Active, not recruiting
- Infection in Solid Organ Transplant Recipients
- Pneumococcal Conjugate Vaccine 13 (PCV13)
-
Los Angeles, CaliforniaUCLA
Aug 9, 2021